These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8737561)

  • 41. [Apropos of "Onychomycoses caused by non-dermatophytic filamentous fungi in Cádiz"].
    del Palacio A; Pazos C; Cuétara S
    Enferm Infecc Microbiol Clin; 2001; 19(7):345-7. PubMed ID: 11747795
    [No Abstract]   [Full Text] [Related]  

  • 42. Tinea incognito due to Trichophyton rubrum responsive to topical therapy with isoconazole plus corticosteroid cream.
    Ghislanzoni M
    Mycoses; 2008 Sep; 51 Suppl 4():39-41. PubMed ID: 18783566
    [No Abstract]   [Full Text] [Related]  

  • 43. [Etiopathogenesis and therapy of dermatophytosis of the nails].
    Buchvald J
    Cas Lek Cesk; 1999 Mar; 138(5):152-5. PubMed ID: 10376399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of human nail etching for the assessment of topical onychomycosis therapies.
    Repka MA; Mididoddi PK; Stodghill SP
    Int J Pharm; 2004 Sep; 282(1-2):95-106. PubMed ID: 15336385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Onychomycosis due to saprophytic fungi].
    Liautaud B; Grosshans E; Basset M
    Presse Med (1893); 1971 May; 79(25):1163-6. PubMed ID: 4253941
    [No Abstract]   [Full Text] [Related]  

  • 46. The importance of mycological investigations in diagnostics of nail changes.
    Maleszka R; Ratajczak-Stefańska V; Mikulska D
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():36-8. PubMed ID: 16119622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
    Sarifakioglu E; Seçkin D; Demirbilek M; Can F
    Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nail sampling in onychomycosis: comparative study of curettage from three sites of the infected nail.
    Shemer A; Trau H; Davidovici B; Grunwald MH; Amichai B
    J Dtsch Dermatol Ges; 2007 Dec; 5(12):1108-11. PubMed ID: 17877741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tinea faciei incognito due to Trichophyton rubrum as a result of autoinoculation from onychomycosis.
    Nenoff P; Mügge C; Herrmann J; Keller U
    Mycoses; 2007; 50 Suppl 2():20-5. PubMed ID: 17681050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of mycoses in patients with circulatory disorders of the lower limbs].
    Eletskaia LV
    Vestn Khir Im I I Grek; 1974 Jul; 113(7):47-50. PubMed ID: 4277959
    [No Abstract]   [Full Text] [Related]  

  • 51. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
    Ginter-Hanselmayer G; Weger W; Smolle J
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Onychomycosis in systemic lupus erythematosus: a case control study.
    Tlacuilo-Parra A; Guevara-Gutierrez E; Mayorga J; Garcia-De La Torre I; Salazar-Paramo M
    J Rheumatol; 2003 Jul; 30(7):1491-4. PubMed ID: 12858446
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Experience in the treatment of onychomycosis with griseofulvin in combination with external antifungal agents].
    Kolokolova NV; Frolova NO
    Sov Med; 1967 Sep; 30(9):141-2. PubMed ID: 4236449
    [No Abstract]   [Full Text] [Related]  

  • 55. Trichophyton rubrum onychomycosis in a 10-week-old infant.
    Sachdeva S; Gupta S; Prasher P; Aggarwal K; Jain VK; Gupta S
    Int J Dermatol; 2010 Jan; 49(1):108-9. PubMed ID: 20465630
    [No Abstract]   [Full Text] [Related]  

  • 56. Onychomycosis in children.
    Chang P; Logemann H
    Int J Dermatol; 1994 Aug; 33(8):550-1. PubMed ID: 7960349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dosage requirements of griseofulvin in onychomycosis due to Trichophyton rubrum. I. Preliminary report.
    DILLAHA CJ; JANSEN GT
    Arch Dermatol; 1960 May; 81():790-6. PubMed ID: 13816771
    [No Abstract]   [Full Text] [Related]  

  • 58. [Onychomycosis: experiences with atraumatic nail avulsion].
    Dorn M; Kienitz T; Ryckmanns F
    Hautarzt; 1980 Jan; 31(1):30-4. PubMed ID: 6446529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Onychomycosis of the feet; treatment with griseofulvin.
    REISNER RM; HOMER RS; NEWCOMER VD; STERNBERG TH
    Calif Med; 1960 Oct; 93(4):217-23. PubMed ID: 13740670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of onychomycosis with a propylene glycol-urea-lactic acid solution.
    Faergemann J; Swanbeck G
    Mycoses; 1989 Oct; 32(10):536-40. PubMed ID: 2531288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.